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Abstract
Background: Traditional inflammatory markers are generally unhelpful in discerning septic arthritis from
inflammatory joint disease due to their lack of specificity. We wished to explore the discriminatory power of the
novel inflammatory marker, Fc-gamma-receptor type 1, CD64, in patients presenting with acute arthritis.
Methods: Patients were recruited prospectively in the time period June 2009 to December 2011. Thirty-six patients
presenting with an acute flare of chronic rheumatic arthritis, 31 with crystal-induced arthritis and 23 with septic
arthritis were included. Traditional inflammatory markers, CD64 and procalcitonin (PCT) were measured and their
diagnostic abilities were compared.
Results: CD64 and PCT both demonstrated a specificity of 98%, but poor sensitivities of 59% and 52%, respectively.
White blood cell count (WBC), and erythrocyte sedimentation rate (ESR) did not have significant discriminatory
power, while C-reactive protein (CRP) proved to have the best diagnostic accuracy as measured by area under the
ROC curve (AUC 0.92, 95% confidence-interval 0.87-0.98). Subgroup analysis excluding patients with septic arthritis
without concurrent bacteremia, and likewise exclusion of the patients with septic arthritis caused by coagulase
negative staphylococci, both improved the diagnostic accuracy of CD64 and PCT, but not of WBC and CRP.
Conclusions: CD64 and PCT are highly specific for infectious disease, but they predominantly measure bacteremia.
Their use in hospital practice has yet to be defined, and especially so in localized infections.
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Background
Untreated, septic arthritis has a significant morbidity and
mortality [1]. Early recognition is important, as prompt
antimicrobial treatment and synovial irrigation reduces
the risk of joint destruction. The clinical features, however,
are indistinguishable from many other causes of arthritis,
especially crystal-induced arthritis (CIA). The diagnosis of
septic arthritis depends largely on positive microbiological
cultures, but the technique is time-consuming and often
delays the final diagnosis by 2–3 days. Furthermore
antimicrobial agents administered prior to admission
to hospital reduce the diagnostic sensitivity, frequently
producing falsely negative results. Traditional inflam-
matory markers such as white blood cell count (WBC),
erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP) are generally unhelpful due to their lack
of specificity [2]. These markers are often elevated
regardless of whether the inflammatory stimulus is
trauma, rheumatic disorders or infectious disease [3].
During the last decade, CD64 has been proposed as a
novel and more specific parameter of infection [4]. CD64,
also called fc-gamma-receptor type 1, is an integral mem-
brane protein of white blood cells [5]. It interacts with
immunoglobulin G with high affinity, and is important for
effective phagocytosis of microbial components and im-
mune complexes. The receptor is constitutively expressed
on the surface of monocytes, macrophages and eosinophil
granulocytes. It is up-regulated on neutrophils as a physio-
logical response to microbial wall components such as
lipopolysaccharide, complement split products, as well as
cytokines (interferon gamma and granulocyte colony
stimulating factor) [6]. The response time is estimated to
4–6 hours [7], making it more versatile than CRP and SR
in acutely ill patients.
It has previously been reported that the quantitative
measurement of CD64 expression on the surface of
neutrophils is a sensitive and specific marker of systemic
infection, even in patients with systemic inflammatory
diseases [8-11]. We wished to explore the discriminatory
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power of CD64 in patients presenting with acute arthritis.
Comparison was conducted with traditional markers
(WBC, SR and CRP) as well as another relatively novel
inflammatory marker, procalcitonin (PCT). We included a
negative and positive control group to strengthen the
foundation for selecting appropriate cut-off values.
Methods
Study setting
Haukeland University Hospital, Bergen, Norway, is the
referral hospital for a population of about 1.1 million
inhabitants and also a local hospital for approximately
350.000 people.
Patient selection
Patients were recruited prospectively from the hospital
in the time period June 2009 to December 2011, inclu-
sion was performed after written informed consent. Four
groups of patients were included:
Group 1 (Negative controls) consisted of presumably
healthy blood-donors.
Group 2 (Positive controls) consisted of patients
admitted to the Emergency room with clinically
suspected upper urinary tract infection (UTI), defined
by a triad of current urinary tract symptoms
(pollakiuria, dysuria, localized bladder/kidney pain, or
urine retention), history of fever within the last 2 days
and positive urine- and/or blood-culture. Patients with
concurrent infectious disease of other etiology were
excluded.
Group 3 consisted of patients with established chronic
rheumatic arthritis (RA, psoriasis arthritis,
oligoarthritis, spondylarthritis or SLE) presenting at the
hospital’s Rheumatology outpatient clinic with an acute
disease flare as assessed by a skilled rheumatologist
(AKH). Infectious etiology was excluded by culture
where indicated.
Group 4 consisted of consecutive patients admitted to
the hospital with the clinical diagnosis of acute
arthritis. Cases were defined by a clinical triade of
localized joint pain, local inflammation (rubor, calor,
tumor, dolor) and pain provoked by passive joint
movement. They were later sub grouped according to
final diagnosis as septic arthritis (defined as positive
blood-/synovial fluid culture and clinically assessed as
infectious etiology by infectious disease specialist),
crystal-induced arthritis (defined as presence of urate-
or pyrophosphate-crystals in synovial joint-fluid and
negative cultures) or other/unknown diagnosis.
Laboratory investigations
Blood was drawn on admission. CD64 expression was
measured by flow cytometry within 48 hours of blood
sampling using the commercially available Leuko64TM-
kit (Trillium Diagnostics, Brewer, ME, USA) containing
calibrated fluorescent beads and antibodies to CD64.
The CD64 index was reported using a lot-specific
Leuko64 Quanti-CALCTM automated software (Trillium
Diagnostics), which calculated the ratio of the mean fluor-
escent intensity of the examined cell-population to that of
the beads. Procalcitonin was measured by the immuno-
logical method electrochemiluminescence (Roche/Hitachi
MODULAR E170), and CRP by immunoturbidimetric
method (Roche/Hitachi MODULAR P). SR and WBC
were analyzed by standard methods by our routine labora-
tory. Arthrocentesis was performed in all patients in group
3 and 4. Synovial fluid samples were cultured for 2 days
from native joints and 5 days from prosthetic joints. Nega-
tive cultures were further examined by 16sRNA PCR
where clinically indicated. The samples were also exam-
ined with acridin-orange and gram-stain by a specialist in
microbiology, and with polarized light microscopy by a
rheumatologist. CD64 expression in synovial fluid was
measured by previously described methods, but too few
samples were analyzed to permit statistical analysis.
Statistical analysis
The data are presented as medians and interquartile
ranges (IQRs). Subgroups were compared using non-
parametric tests (Mann–Whitney U-test). Statistical sig-
nificance was considered at p < 0.05. Receiver-operating
characteristics (ROC) curves were created for CD64-
index, procalcitonin, CRP and WBC, and were used to
establish optimal cut-off values. They also permitted
calculation of sensitivity, specificity and area under the
ROC curve (AUC). The SPSS software version 20.0 for
windows (SPSS Science, Chicago, IL, USA) was used for
statistical analysis.
Ethical considerations
The project was approved by the Regional Ethic commit-
tee for Medical research in Western Norway prior to the
commencement of the study.
Results
Group 1 (blood-donors) included 25 participants. Base-
line characteristics/demographics for all groups are
presented in Table 1.
In group 2 (Upper urinary tract infection, UTI), 34
patients were assessed for participation. Seven were ex-
cluded (two with pneumonia, five with polymicrobial
urinary culture). Of the 27 included, nine had positive
blood culture, 26 had positive urinary culture. E. coli
was the most frequent microbe encountered (59%),
followed by Klebsiella species (11%) and Enterococcus
species (11%). For two patients CD64-analysis was
lacking.
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In group 3 (Flare of rheumatic arthritis, FRA), 36
patients were included, eight lacked CD64-analysis. The
majority of patients suffered from rheumatoid arthritis
(39%) and psoriatic arthritis (36%), while the rest consisted
of oligo-/polyarthritis (14%) and reactive arthritis (11%).
In group 4 (acute arthritis), 67 patients with acute
arthritis were assessed for participation, nine were
excluded due to uncertain final diagnosis. Four patients
presented with acute arthritis but had spontaneous recov-
ery without the administration of antibiotics. Although no
firm diagnosis could be established, they were considered
to be of non-bacterial etiology and grouped separately.
When calculating the inflammatory markers diagnostic
accuracy in discerning infectious from non-infectious eti-
ology, they were grouped with the non-infectious cases
(FRA and CIA). Twenty-three had culture-proven septic
Table 1 The baseline characteristics and measured parameters of the study subjects
Blood donor UTI FRA CIA SA
Cases 25 27 36 31 23
Age 40 (29–57) 66 (29–79) 48 (35–65) 76 (57–87) 60 (47–72)
Sex M/F 17/8 15/12 14/22 21/10 16/7
CD64-index 0.6 (0.5–0.8) 4.9 (2.5–7.8) 1.0 (1.0–1.2) 1.4 (0.9–1.9) 2.3 (0.8–9.3)
PCT (mg/L) ND 1.29 (0.26–4.42) 0.10 (0.10–0.10) 0.11 (0.10–0.18) 1.27 (0.14–4.41)
CRP (mg/L) ND 123 (84–235) 23 (8–80) 84 (51–162) 239 (172–308)
WBC (x109/L) 5.3 (4.0-6.3) 16.4 (10.6–18.8) 8.2 (6.8–10.5) 9.8 (8.4–12.1) 11.7 (7.8–13.4)
ESR (mm/t) ND 55 (36–68) 34 (20–63) 52 (41–71) 77 (63–104)
Data presented as median (inner quartile range). UTI urinary tract infection, FRA flare of rheumatic arthritis, CIA crystal induced arthritis, SA septic arthritis, M male,
F female, PCT procalcitonin, CRP C-reactive protein, WBC white blood cell count, ESR erythrocyte sedimentation rate, ND no data.
Table 2 Characteristics of septic arthritis cases
NJ/ PJ Microbe Joint culture Blood culture CD64 index PCT CRP WBC Joint Dur. of sympt. AB prior to adm
1 NJ GGS + + 3.2 2.54 239 16.0 Knee 4 d Yes
2 NJ GGS + + 7.3 16.20 219 12.1 Wrist 2 d No
3 NJ GGS + + ND 1.66 286 16.9 Hip 6 d No
4 NJ GGS + - ND 5.75 84 13.4 Shoulder 1 d No
5 NJ S.pneumoniae + + 2.4 0.25 273 9.1 Ankle 9 d Yes
6 NJ E.faecalis + - 2.3 1.28 266 9.3 Knee 4 d Yes
7 NJ S.aureus - + ND 24.30 148 9.6 Shoulder 1 d No
8 NJ S.aureus + + 13.0 2.98 308 29.4 Knee 3 d No
9 NJ S.aureus + + 17.0 2.14 379 6.1 Shoulder 7 d No
10 NJ S.aureus + + ND 25.30 438 12.3 Shoulder 5 d No
11 NJ S.aureus + - ND <0.10 81 6.7 Knee 10 d No
12 NJ S.aureus + - 0.8 <0.10 158 12.9 Ankle 3 d No
13 NJ S.aureus + - ND 0.13 123 11.8 Knee 13 d Yes
14 NJ S.lugdunensis + - 2.0 0.17 303 8.5 Knee 2 d No
15 NJ S.lugdunensis + - 0.6 0.14 220 7.6 Knee 4 d No
16 NJ S.lugdunensis + - 0.7 0.32 344 11.7 Knee 7 d No
17 PJ1 S.epidermidis + - 0.7 <0.1 247 7.8 Knee 4 d No
18 PJ1 S.capitis + - 0.6 <0.10 183 10.2 Knee 3 d No
19 PJ1 S.capitis + - 0.8 0.24 199 6.5 Knee 7 d Yes
20 PJ1 S.aureus + + 2.7 4.41 232 6.4 Hip 3 d No
21 PJ1 S.aureus + + 2.3 0.35 172 14.4 Knee 1 d No
22 PJ2 S.aureus + + 16.3 9.11 319 12.8 Hip 6 d No
23 PJ2 B.holmesii - + 11.2 1.27 335 14.0 Hip 3 d No
NJ native joint, PJ prosthetic joint, 1Early prosthetic infection (< 3 months); 2Late prosthetic infection (>12 months); PCT procalcitonin, CRP C-reactive protein, WBC
white blood count, Dur. of sympt, duration of symptoms prior to admission in days; AB prior to adm., antibiotics administered prior to admission; GGS group G
streptococci, ND no data.
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arthritis, whereof seven were related to prosthetic joints.
The characteristics of the septic arthritis cases are
presented in Table 2. Twelve had positive blood cultures,
while 21 had positive joint fluid cultures. None were
diagnosed by 16sRNA-PCR or microscopy alone. The
microbial etiology comprised S.aureus (44%), group G
streptococci (18%), coagulase negative staphylococci
(26%), E.faecalis (4%), Bordetella holmesii (4%) and S.
pneumoniae (4%). Six inclusions lacked CD64-analysis.
Thirty-one patients were found to have crystal-induced
arthritis by examination of joint fluid by polarized light
microscopy (15 gout and 16 pseudo gout). Six of these
lacked CD64 and one lacked procalcitonin analysis.
The results of the inflammatory markers are presented
in Figure 1. The CD64-index among blood donors showed
a median of 0.6 (IQR 0.5-0.8), urinary tract infection
(UTI) 4.9 (2.5-7.8), flare of rheumatic arthritis (FRA) 1.0
(1.0-1.2), crystal-induced arthritis (CIA) 1.4 (0.9-1.9) and
septic arthritis (SA) 2.3 (0.8-9.3). There were significant
differences between SA and CIA (p = 0.03), and between
SA and FRA (p = 0.001). The PCT among UTI patients
showed a median of 1.29 mg/L (IQR 0.26-4.42), FRA 0.10
(0.10-0.10), CIA 0.11 (0.10-0.18) and SA 1.27 (0.14-4.41).
There was a significant difference between SA and CIA
(p < 0.001) and between SA and FRA (p < 0.001). The
CRP-level among UTI patients showed a median of 123
mg/L (IQR 84–235), FRA 23 (8–80), CIA 84 (51–162) and
SA 239 (172–308). Significant differences were found
between SA and CIA (p < 0.001), and between SA and
FRA (p < 0.001). There were no significant differences
found in the WBC and ESR-levels between SA and CIA
(both p = 0.3).
Figure 1 Serum concentrations of the inflammatory markers. Serum concentrations of CD64 (A), procalcitonin (B), CRP (C) and white blood
count (D) among healthy blood donors (BLOOD), patients with flare of rheumatic arthritis (FRA), crystal-induced arthritis (CIA), septic arthritis (SA)
and urinary tract infection (UTI). Horizontal lines indicate cut-off values for CD64 (A) and PCT (B), derived from ROC curve analysis. PCT values
above 5 mg/L are plotted as 5 mg/L.
Table 3 Diagnostic abilities of CD64, PCT and CRP in discerning septic arthritis from non-infectious arthritis
Sensitivity Specificity AUC AUC*
CD64 (cutoff 2.2) 59% 98% 0.69 (0.51–0.88) 0.92 (0.78–1.00)
PCT (cutoff 0.50) 52% 98% 0.85 (0.74–0.96) 0.90 (0.79–1.00)
CRP (cutoff 120) 91% 76% 0.92 (0.87–0.98) 0.91 (0.84–0.98)
CRP (cutoff 240) 48% 98%
PCT in mg/L; CRP in mg/L; AUC area under the curve (95% confidence-interval), AUC*, area under the curve when excluding septic arthritis cases caused by
coagulase negative staphylococci.
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ROC-curves were constructed to assess optimal cut-
off points and compare diagnostic reliability. When
compared by AUC, CRP (AUC 0.92, 95% confidence-
interval 0.87-0.98) was found to be the most reliable
marker for discrimination between infectious arthritis
(SA) and non-infectious arthritis (FRA and CIA)
(Table 3). It was followed by PCT (AUC 0.85 (0.74-0.96))
and CD64 (AUC 0.69 (0.51-0.88)), while WBC did not
have significant discriminatory power. The ROC curves
indicated an optimal cut-off-point for CD64 index at
2.2 and PCT at 0.50 mg/L. This yields a sensitivity of
59% and 52%, and a specificity of 98% and 98% re-
spectively (Table 3).
Subgroup analysis was conducted to evaluate the in-
fluence of the causative agent being coagulase negative
staphylococci (CNS) on the discriminatory power of
the inflammatory markers. When this patient group
was excluded from analysis CD64 showed the greatest
AUC of 0.92 (0.78-1.00), followed by CRP (AUC 0.91
(0.84-0.98)) and PCT (AUC 0.90 (0.79-1.00)). It ap-
peared that excluding SA caused by CNS significantly
improved the diagnostic reliability of CD64 and PCT
(p = 0.001 and p = 0.01 respectively), while there were
no statistically significant differences in the CRP or
WBC values between SA caused by CNS versus other
microbial etiology (p = 0.81 and p = 0.06 respectively)
(Figure 2).
We further investigated the effect of septic arthritis
with concurrent bacteremia versus local joint infection
only. Figure 3 illustrates that with the CD64 index there
was an almost complete segregation of the two groups,
and a tendency towards the same concerning PCT. The
values for CD64 and PCT did not differ significantly
between patients with native or prostethic joints (p = 0.77
and p = 0.5 respectively).
Discussion
The search for better diagnostic tools for identifying
infectious disease is continuously ongoing. CD64 has
previously been reported to, more reliably than CRP,
differentiate systemic infections from rheumatic disease
[8], surgical trauma [10] and viral infection [11]. To our
knowledge, this is the first report on the use of CD64 in
discerning septic arthritis from inflammatory joint
disease. Doi et al. investigated the use of CD64 in
patients with local inflammatory disease, including 22
patients with crystal induced arthritis [12]. They found
low values for CD64 in all patients with CIA, but they
did not perform comparison to patients with infectious
arthritis.
Figure 2 Influence of low-pathogenicity microbial etiology. Serum concentrations of CD64 (A), procalcitonin (B), CRP (C) and white blood
count (D) among patients with flare of rheumatic arthritis (FRA), crystal-induced arthritis (CIA), septic arthritis caused by coagulase negative
staphylococci (SA CNS) and septic arthritis with other microbiological agent (SA other). Horizontal lines indicate cut-off values for CD64 (A) and
PCT (B), derived from ROC curve analysis. PCT values above 5 mg/L are plotted as 5 mg/L.
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We found CD64 to have comparable characteristics to
procalcitonin. Both methods display a high specificity of
98%, and can be useful as a rule-in marker. However,
their poor sensitivities make it difficult to rule out infec-
tious disease. WBC and ESR were generally unhelpful,
while CRP proved to have the best diagnostic accuracy
as measured by AUC.
The most striking characteristic for CD64 and PCT in
the present study was their apparent unresponsiveness
to local infection. The subgroup of septic arthritis pa-
tients with positive blood cultures all had CD64 values
above cut-off. Patients with negative blood cultures, on
the other hand, had almost exclusively values below cut-
off, and were indistinguishable from patients with crystal
induced arthritis. Subgroup analysis in group 2 (UTI) for
patients with and without and bacteremia, did not show
the same segregation. This can partly be explained by
the patient selection, since systemic affection (fever) was
one of the inclusion criteria for this group. Our results
indicate that CD64 and PCT predominantly measure
systemic effects, and are less useful in identifying local-
ized infections. This is in accordance with several previ-
ous reports on PCT and septic arthritis [13-15].
The cut-off value of 2.2 for CD64 correlates well with
other studies employing Leuko64-kit [16-18]. This
yielded a sensitivity of 59% and specificity of 98%. This
is lower than a cumulative sensitivity of 79% and specifi-
city of 91% found in a recent meta-analysis [4], although
this meta-analysis mainly consisted of systemic infec-
tions. A novel meta-analysis by Li et al. examined 26
studies, and calculated a pooled sensitivity and spe-
cificity of 76% and 85%, respectively. The subgroup
consisting of proven culture-verified infections, however,
displayed a sensitivity of 78% and a specificity of 91%
[19]. Tanaka et al. examined CD64 in local musculoskel-
etal infections, finding comparable diagnostic accuracy
to our results with a sensitivity of 66% and a specificity
of 96% [20].
The lower sensitivity for infection in our material
compared to several previous studies may partly be
explained by the high share in the present study of
bacteria of low virulence, generating little inflammatory
response. Accordingly, the exclusion of coagulase nega-
tive staphylococci from the analysis yielded significantly
better diagnostic accuracy, and provided CD64 with the
greatest AUC.
Furthermore, some studies have indicated a trend to-
wards lower CD64 response to gram-positive bacteria
than to gram-negatives [8], and the microbial flora in
our cohort comprised mainly gram-positive bacteria.
The varied microbial pathogenicity and the inclusion of
prosthetic joint-infections impose difficulties interpreting
Figure 3 Effect of localized versus systemic infection. Serum concentrations of CD64 (A), procalcitonin (B) ), CRP (C) and white blood count
(D) among patients with crystal-induced arthritis (CIA), septic arthritis with positive blood culture (SA BC-positive) and septic arthritis with
negative blood culture (SA BC-negative). Horizontal lines indicate cut-off values for CD64 (A) and PCT (B), derived from ROC curve analysis. PCT
values above 5 mg/L are plotted as 5 mg/L.
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the results, but are likely to reflect the cases encountered
in hospital practice.
The use of culture as a gold standard for diagnosing
septic arthritis is hampered by its lack of sensitivity,
especially when antibiotics have been administered prior
to admission. Inevitably, the etiology will remain elusive
in some cases of acute arthritis, and the number of false
negative cultures in the present study is accordingly un-
known. The effect of excluding nine acute arthritis-cases
due to uncertain final diagnosis is difficult to predict,
but could potentially influence the calculated diagnostic
accuracy of the inflammatory markers. The study is
further limited by the lack of CD64-measurement in a
subset of the inclusions.
CD64 has a short turnaround-time (1–2 hours) and is
easily measured with flow cytometry. It has a quicker
physiological response than CRP and SR, and cost is
comparable to PCT. Their poor sensitivity in local infec-
tions, however, makes them unlikely to replace the current
inflammatory markers used in hospital practice. CD64
was measured occasionally, but not systematically, in joint
fluid specimens. Without exception the values were higher
than their corresponding blood values, but the numbers
were too small for statistical analysis. It is feasible that
direct measurement of CD64 in joint fluid could prove
more sensitive for local infection, and further studies are
warranted to explore this possibility.
Conclusions
CD64 and PCT are highly specific for infectious disease,
including septic arthritis, and can be useful as rule-in
markers. Their poor sensitivity in local infections, how-
ever, makes them unlikely to replace the current inflam-
matory markers used in hospital practice.
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